StoneRidge PMG Advisors, LLC’s Elevance Health ELV Stock Holding History

StoneRidge PMG Advisors, LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$908K	Buy	+2,335	New	+$932K	0.64%	30

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ACR Alpine Capital Research St. Louis, Missouri $7.35B AUM 21.37% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Beutel, Goodman & Co Toronto, Ontario, Canada $12.7B AUM 12.76% 1-Year Est. Return

Focused Investors Los Angeles, California $2.41B AUM 10.28% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

StoneRidge PMG Advisors, LLC's ELV Position: Q3 2026 in Review

StoneRidge PMG Advisors, LLC opened a new position in Elevance Health (ELV) in Q3 2026: 2,335 shares worth $908K. The stake represents 0.64% of the portfolio and ranks #30 among its holdings.

762 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

StoneRidge PMG Advisors, LLC held 2,335 shares of Elevance Health worth $908K as of Q3 2026.
Elevance Health was a new StoneRidge PMG Advisors, LLC position in Q3 2026.
Elevance Health made up 0.64% of StoneRidge PMG Advisors, LLC's portfolio in Q3 2026, its #30 holding.
762 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on StoneRidge PMG Advisors, LLC's 13F filing for Q3 2026, filed 4 Nov 2026.